November 19, 2018
In a scientific collaboration with Dr Armelle Cuvillier, Chair & CSO of B-Cell Design, a dynamic biotech company based in Limoges, France, we have presented R&D program results, for the first time, at the 4th International Vaccine R&D Conference, Baltimore MD, 14 November (validated animal model, human cohort study). This program was carried...
June 18, 2018
The 2nd Boston/Paris Biotechnology Summit was held on Sunday 3 June 2018 at the Boston Exchange Conference Center, just prior to the 2018 BIO Convention held in Boston MA. The Boston – Paris Biotechnology Summit is an exclusive, trans-Atlantic bridge designed to foster innovative synergies between biotech and pharma companies, healthcare-focused...
May 31, 2018
Boston-Paris Biotechnology Summit®: Bringing Together Leaders to Bridge Business Partnerships A Day of Learning and Meeting on New Sources of Financing and Strategic Partnerships Boston, Massachusetts – 30 May, 2018 -The BOSTON-PARIS Biotechnology Summit®, an international conference that aims to foster innovation and partnerships...
April 30, 2018
Shahin Gharakhanian MD Consulting LLC is pleased to announce, in the capacity as Chairman & Co-founder, the 2nd Boston ● Paris Biotechnology Summit® @ Boston Exchange Conference Center, 3 JUNE 2018 – A Day of Entrepreneurship & Science To Drive Therapeutic Progress Research, Development, obtaining Regulatory Approval and Launching a new...
February 14, 2018
Shahin Gharakhanian MD Consulting LLC based in Cambridge MA, USA, starts its sixth year of activity in clinical development and medical affairs. We very sincerely thank all the companies and organizations who reached out for projects and long term collaboration in various therapeutic areas for their confidence. LLC Projects/Collaborations 2012 –...
December 12, 2017
The 2nd Boston Medical Affairs Seminar was held under the direction of Shahin Gharakhanian MD and Barry Lubarsky PhD (Sr Medical Director, Alkermes), in Boston, 12.2017. Seminar Abstract is as follows: During the past decade, Medical Affairs has become a critical function within all pharmaceutical and biotechnology companies. A high-performance Medical...
December 1, 2017
Critical review of Therapeutic Vaccines for the Functional Cure of the HIV Infection: lessons learned within clinical development programs, 2011-2017. ABSTRACT Functional cure without eradication of HIV-1, implies effective host immunity to control HIV replication. This hypothesis is based on the strong immune responses observed in limited cohorts...
June 12, 2017
The mission of the 1st Boston Paris Biotechnology Summit™ was to act as a novel catalyst to provide facilitative leadership for talents in both cities and thus foster energies and synergies, spark new projects and generate funding opportunities. This successful summit was held on 18 May 2017, 8hr-19hr, in the historic Amphitheatre Duclaux at Institut...
September 28, 2012
Clinical Development in Chronic Viral Disease:Reflections and Experiences from Hepatitis C and HIV Infection. Lecture @ Division of Infectious Diseases, Brigham & Womans Hospital, Harvard Medical School, 30 July 2012 Valuable role of medical affairs in new drug approval and launch Medical Affairs Executive Forum, 12-13 April 2012, Morristown NJ. https://exlpharma.boxenterprise.net/medical...
September 28, 2012
Gharakhanian S, Kotler DP. Diabetes mellitus, HIV infection, and vitamin D: time to act or time to think? AIDS 2011;25:531-3. Hézode Ch, Forestier N, Dusheiko G, Ferenci P, Pol S; Goeser T; Bronowicki J-P, Bourlière M, Gharakhanian S, Bengtsson L, McNair L, George S, Kieffer T, Kwong A, Kauffman R.S; Alam J, Pawlotsky J-M, Zeuzem S. Telaprevir and...